A two-day conference held by Sterne, Kessler, Goldstein & Fox P.L.L.C., which focused on on recent trends in substantive case law, their impact on patent prosecution and examination, and implications regarding the enforcement of patents in the pharmaceutical and biopharmaceutical industry.